Bill Snyder Archive — Page 101 of 121

Close-up of an older adult’s eye, showing a small circular implant visible in the iris area.
October 2, 2014

Regenerative visual neuroscience effort launched

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.

Jeff Balser speaks onstage in a suit and tie, raising one hand beside a large projected map or diagram.
September 25, 2014

VUMC well positioned to move forward: Balser

U.S. Sen. Lamar Alexander speaks with three Vanderbilt University Medical Center faculty members in a bright facility lobby; one wears a white lab coat, and other visitors and staff stand in the background.
September 24, 2014

Alexander’s visit highlights efforts to confront Ebola

Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.

U.S. Sen. Lamar Alexander speaks with three Vanderbilt University Medical Center faculty members in a bright facility lobby; one wears a white lab coat, and other visitors and staff stand in the background.
September 24, 2014

Alexander’s visit highlights efforts to confront Ebola

Don’t panic over Ebola. But don’t ignore it, either. That was the take-home message for U.S. citizens from a “mini-hearing” held by U.S. Sen. Lamar Alexander, R-Tenn., at Vanderbilt University Medical Center on Wednesday with researchers and health officials from Vanderbilt and the State of Tennessee.

A graduate researcher in gloves adjusts a multiwell plate inside laboratory equipment while a senior scientist in a white coat observes.
September 18, 2014

Initiative seeks to develop therapies to combat Ebola

Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses.

Black outline of a human head in profile containing a concentric target with an arrow pointing to its center, against a blue-and-white gradient background.
September 12, 2014

Schizophrenia ‘switches’ discovered

Drugs developed at Vanderbilt could provide a new way to treat schizophrenia in a personalized way.